To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Coronavirus: Medical Treatments
Monday 8th March 2021

Asked by: Baroness Scott of Needham Market (Liberal Democrat - Life peer)

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of the use of steroid inhalers for the prevention of serious symptoms of COVID-19.

Answered by Lord Bethell

The Department has monitored a collection of small studies which have now completed and provided some positive signals on inhaled steroids. This includes the STOIC study at Oxford University which examined the use of inhaled budesonide, a corticosteroid, in the treatment of early COVID-19. STOIC published results which are undergoing peer review. However, larger-scale studies are still needed to confirm the effectiveness and safety of such treatments.


Written Question
Chronic Fatigue Syndrome
Tuesday 29th December 2020

Asked by: Baroness Scott of Needham Market (Liberal Democrat - Life peer)

Question to the Department of Health and Social Care:

To ask Her Majesty's Government why Chronic Fatigue Syndrome (CFS) is not listed on the topics covered by the NHS Clinical Knowledge summary; who authorised the decision to combine CFS with “Tiredness/fatigue in adults”; and when that change was made.

Answered by Lord Bethell

The National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summary Tiredness/fatigue in adults was published in October 2009 and there has been no change in the way it is titled over the subsequent period. NICE advises that the inclusion of Chronic Fatigue Syndrome (CFS) within the tiredness/fatigue topic is to ensure that clinicians will consider CFS as a potential diagnosis as early as possible in the course of care of a person presenting with symptoms of tiredness and fatigue.

In 2007 NICE published the guideline, Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management. This is currently being updated and a draft guideline is out for consultation with the final guidance expected in April 2021. The CFS diagnosis and management sections in the Clinical Knowledge Summary on Tiredness/Fatigue are kept in line with NICE guidance on CFS and will be updated following publication of the new guidance if necessary.


Written Question
Coronavirus: Older People
Wednesday 6th May 2020

Asked by: Baroness Scott of Needham Market (Liberal Democrat - Life peer)

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to reports of the increased risk of serious COVID-19 related illness in the over 60s, what work they are conducting to assess the increased risk of over 60s working in the care system, and in particular, those who have come out of retirement to support services during the pandemic.[T]

Answered by Lord Bethell

We are very grateful to all those working in social care for their incredible commitment to caring for others at this difficult time; we are especially thankful to those who have returned to work or come out of retirement to support services to deliver the best possible care.

We expect every employer to ensure that each employee is undertaking a role that is appropriate to their skills, experience, and personal circumstances. This is the case whether the employee is a permanent member of staff, or somebody who has returned to the sector to help care for and support people during the pandemic. Where, because of their own circumstances, an employee needs to shield themselves, then a social care employer is able to place these staff on furlough.


Written Question
European Union
Friday 20th February 2015

Asked by: Baroness Scott of Needham Market (Liberal Democrat - Life peer)

Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what was the total cost of the Review of the Balance of Competences between the United Kingdom and the European Union to the Department of Health, broken down by (1) staff time, (2) printing costs, (3) running of engagement events, (4) witness expenses, (5) publicity of the reports, and (6) any and all other associated costs.

Answered by Earl Howe - Deputy Leader of the House of Lords

The Balance of Competences Review concluded in December. It was the most comprehensive analysis of the United Kingdom’s relationship with the European Union ever undertaken. The Review involved a large number of Departments across Whitehall to produce the 32 reports. The Review was based on the evidence and views received through widespread consultation with interested parties from across society. Across the whole review, departments received close to 2,300 evidence submissions. Departments held over 250 events, attended by around 2,100 stakeholders.

It was important that what is an unprecedented examination of EU membership was done with appropriate time and care. But the government is also very conscious of the need to ensure value for money in everything that it does.

Work on the Review was allocated according to need to existing staff within the Department. Providing a full breakdown of staff time and costs would exceed the disproportionate cost threshold

The Department paid £3,473.00, excluding VAT, for printing and publication of the Health report. During the course of the Health Review, five events were held at a total cost of £183.48.

Across the whole of the Balance of Competences Review witness expenses amounted to approximately £2,255.00. No costs were incurred in publicising the report. There were no other associated costs for the Department of Health.